EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

The effects of nanocurcumin supplementation on inflammation in hemodialysis patients: A randomized controlled trial

Golchin Vafadar-Afshar iD, Yousef Rasmi, Parichehreh Yaghmaei, Mohammad-Hassan Khadem-Ansari, Khadijeh Makhdoomi, Javad Rasouli

Hemodialysis International · 2021-04 · 25 (2) · 232-239

DOI: 10.1111/hdi.12911 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Hemodialysis International, online erschienen am 08.02.2021. Verfasst von Golchin Vafadar-Afshar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran. Hauptthemen laut MEDLINE: Leukocytes, Mononuclear, Renal Dialysis. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Serum levels of several pro‐inflammatory cytokines are higher in hemodialysis patients compared to healthy people. Curcumin has been shown to be able to decrease cytokines levels in nonuremic subjects. Our goal was to evaluate the effect of nanocurcumin administration on cytokines levels in hemodialysis patients.

Methods

The study was performed over a 3 months period on 54 hemodialysis patients who had been randomized to receive either nanocurcumin or placebo. Serum levels and gene expressions of tumor necrosis factor‐alpha (TNF‐α) and interleukin 6 (IL‐6) were evaluated using enzyme‐linked immunosorbent assay (ELISA) and real‐time polymerase chain reaction (RT‐PCR).

Findings

Serum levels of IL‐6 and TNF‐α were similar in the two groups at baseline but were lower after 12 weeks of treatment with nanocurcumin compared to placebo ( P = 0.024 for IL‐6 and 0.02 for TNF). In the group given nanocurcumin, serum levels of both cytokines decreased substantially ( P < 0.001 for each), whereas they were unchanged in the group given placebo. Gene expression for each cytokine in peripheral blood mononuclear cells (PBMCs) was reduced at 12 weeks vs. baseline in the group given nanocurcumin, and changes in gene expression correlated with changes in serum level for each of the two cytokines.

Discussion

The results indicate that nanocurcumin supplementation reduces both serum levels and gene expression of IL‐6 and TNF‐α in hemodialysis patients. The feasibility and potential clinical benefits of nanocurcumin treatment to reduce inflammation in hemodialysis patients warrant further study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukocytes, MononuclearRenal DialysisCytokinesDietary SupplementsHumansInflammationTumor Necrosis Factor-alpha

Stichwörter der Autor:innen

Gene expressionIL-6PBMCTNF-αhemodialysisnanocurcumin

Substanzen

CytokinesTumor Necrosis Factor-alpha

Autor:innen und Institutionen

  • Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.
  • Department of Biochemistry, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran.
  • Cellular and Molecular Research Center, Urmia University of Medical Sciences, Urmia, Iran.
  • Department of Nephrology, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran.
  • Department of Epidemiology and Biostatistics, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran.

ORCID-Profile: Golchin Vafadar-Afshar

Zitieren

APA

Vafadar-Afshar, G., Rasmi, Y., Yaghmaei, P., Khadem-Ansari, M. H., Makhdoomi, K., & Rasouli, J. (2021). The effects of nanocurcumin supplementation on inflammation in hemodialysis patients: A randomized controlled trial. Hemodialysis International, 25(2), 232-239. https://doi.org/10.1111/hdi.12911

Vancouver

Vafadar-Afshar G, Rasmi Y, Yaghmaei P, Khadem-Ansari MH, Makhdoomi K, Rasouli J. The effects of nanocurcumin supplementation on inflammation in hemodialysis patients: A randomized controlled trial. Hemodialysis International. 2021;25(2):232-239. doi:10.1111/hdi.12911

BibTeX
@article{VafadarAfshar2021,
  author = {Vafadar-Afshar, Golchin and Rasmi, Yousef and Yaghmaei, Parichehreh and Khadem-Ansari, Mohammad-Hassan and Makhdoomi, Khadijeh and Rasouli, Javad},
  title = {The effects of nanocurcumin supplementation on inflammation in hemodialysis patients: A randomized controlled trial},
  journal = {Hemodialysis International},
  year = {2021},
  volume = {25},
  number = {2},
  pages = {232--239},
  doi = {10.1111/hdi.12911}
}
Kostenlos starten →